NCT04004728

Brief Summary

Is 1064 nm YAG Laser better than sclerotherapy to treat leg veins?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

September 21, 2011

Completed
7.8 years until next milestone

First Posted

Study publicly available on registry

July 2, 2019

Completed
Last Updated

July 2, 2019

Status Verified

June 1, 2019

Enrollment Period

1.4 years

First QC Date

September 21, 2011

Last Update Submit

June 27, 2019

Conditions

Keywords

lasertelangiectasiasleg veinssclerotherapy

Outcome Measures

Primary Outcomes (4)

  • Changes analysis after treatments of leg telangiectasias´clearance through photography using a scale of improvement.

    Patients are asked about the best method to treat leg veins after three treatments of laser and three treatments of sclerotherapy. Evaluation of the photographic improvement of the treated areas on a scale of 0 (no improvement) to 10 (complete cleaning of the vessels).

    Analysis of photographic changes previous, and one week after treatment. Patient reanalysis after 1 and 3 months

  • Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the pain

    Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying the pain (none, little, very painful or extremely painful).

    1 week after treatment

  • Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the cleaning of vessels

    Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying the cleaning of vessels (poor, regular, good or excellent)

    1 week after treatment

  • Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the satisfaction with results

    Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying satisfaction with results (nothing, little or much

    1 week after treatment

Study Arms (1)

laser, leg veins, sclerotherapy

OTHER

to compare laser and sclerotherapy on treating leg veins

Procedure: 1064 Nd:YAG laser

Interventions

1064 laser - 135J 25ms spot 3mm GLicose - 75% - 3 ml

laser, leg veins, sclerotherapy

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with leg telangiectasias

You may not qualify if:

  • varicose veins
  • DVT
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vascular Surgery HCFMUSP

São Paulo, 04534000, Brazil

Location

MeSH Terms

Conditions

Telangiectasis

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Nelson Wolosker, MD, PhD

    Hospital das Clinicas, University of Sao Paulo

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Blind photo evaluation.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: One leg laser ando the other sclerotherapy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Associate Professor, MD, PhD

Study Record Dates

First Submitted

September 21, 2011

First Posted

July 2, 2019

Study Start

March 1, 2010

Primary Completion

August 1, 2011

Study Completion

September 1, 2011

Last Updated

July 2, 2019

Record last verified: 2019-06

Locations